Profil
Yi Liu was the founder of Kura Oncology, Inc. (2014, Chief Scientific Officer), Intellikine LLC (2007, Vice President-Drug Discovery), and Kumquat Biosciences, Inc. (2018, Chief Executive Officer & Director).
Former jobs include Principal at CuraGen Corp., Chief Scientific Officer at Zeta Acquisition Corp.
III, Principal at SGX Pharmaceuticals, Inc., Head-Drug Design Group at Novartis Institute for Functional Genomics, Inc., and Chief Scientific Officer at Wellspring Biosciences LLC (2012-2014).
Education includes a doctorate from Princeton University, an undergraduate degree from Tsinghua University, and a graduate degree from Beijing University of Technology.
Aktive Positionen von Yi Liu
| Unternehmen | Position | Beginn |
|---|---|---|
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Gründer | 01.11.2018 |
Ehemalige bekannte Positionen von Yi Liu
| Unternehmen | Position | Ende |
|---|---|---|
Wellspring Biosciences LLC
Wellspring Biosciences LLC Pharmaceuticals: MajorHealth Technology Discovers and develops molecule drugs targeting signal transduction networks for the treatment of cancer and other diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2014 |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Gründer | 01.05.2012 |
Zeta Acquisition Corp. III
Zeta Acquisition Corp. III MiscellaneousMiscellaneous Operates as a blank check company | Technik-/Wissenschafts-/F&E-Leiter | - |
| KURA ONCOLOGY, INC. | Gründer | - |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Yi Liu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Zeta Acquisition Corp. III
Zeta Acquisition Corp. III MiscellaneousMiscellaneous Operates as a blank check company | Miscellaneous |
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs and other pharmaceutical products | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Health Technology |
Beijing University of Technology
Beijing University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wellspring Biosciences LLC
Wellspring Biosciences LLC Pharmaceuticals: MajorHealth Technology Discovers and develops molecule drugs targeting signal transduction networks for the treatment of cancer and other diseases | Health Technology |
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
















